Have just been looking back over the announcements.
There were three announcements for ethics trial approval prior to an announcement for FDA IND approval for PD1 vaxx. There was no announcement for IND request. Several early announcements stated a Q4 2020 trial start date, and that is what was achieved.
In Aug 2020 there is announcement about the Pre IND meeting for Vaxinia. So I guess we should see some ethic approvals next, and then IND approval?
This timeline looks like it might have the order of things a bit mixed up.
IMUGENE CHART. TA only, page-244
-
- There are more pages in this discussion • 32,839 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.003(5.36%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 6.1¢ | 5.6¢ | $1.239M | 21.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1459482 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 633310 | 6 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |